1,223
Views
0
CrossRef citations to date
0
Altmetric
Research Paper

Role of circRNA circ_0000080 in myocardial hypoxia injury

, , &
Pages 10902-10913 | Received 04 Jan 2022, Accepted 08 Apr 2022, Published online: 27 Apr 2022

References

  • Lu L, Liu M, Sun R, et al. Myocardial infarction: symptoms and treatments. Cell Biochem Biophys. 2015;72(3):865–867.
  • de Lemos Ja, Newby LK, Mills NL, et al. A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction. Circulation. 2019;140(22):1773–1775.
  • Krishnaswami A, Maurer MS, Alexander KP. Contextualizing myocardial infarction: comorbidities and priorities in older adults. Am J Med. 2017;130(10):1144–1147.
  • Velibey Y, Erbay A, Ozkurt E, et al. Acute myocardial infarction associated with blood transfusion: case report and literature review. Transfus Apher Sci. 2014;50(2):260–262.
  • Nikulina NN, Yakushin SS. the modern aspects of diagnosis formulation and statistical recording of myocardial infarction. Kardiologiia. 2016;56:60–66.
  • Jin J, Sun H, Shi C, et al. Circular rna in renal diseases. J Cell Mol Med. 2020;24(12):6523–6533.
  • Altesha MA, Ni T, Khan A, et al. Circular rna in cardiovascular disease. J Cell Physiol. 2019;234(5):5588–5600.
  • Lu D, Thum T. Rna-based diagnostic and therapeutic strategies for cardiovascular disease. Nat Rev Cardiol. 2019;16(11):661–674.
  • Hsiao KY, Sun HS, Tsai SJ. Circular rna - new member of noncoding rna with novel functions. Exp Biol Med. 2017;242(11):1136–1141.
  • Garikipati VNS, Verma SK, Cheng Z, et al. Circular rna circfndc3b modulates cardiac repair after myocardial infarction via fus/vegf-a axis. Nat Commun. 2019;10(1):4317.
  • Zeng Z, Xia L, Fan S, et al. Tang WH: circular rna circmap3k5 acts as a microrna-22-3p sponge to promote resolution of intimal hyperplasia via tet2-mediated smooth muscle cell differentiation. Circulation. 2021;143(4):354–371.
  • Li H, Xu JD, Fang XH, et al. Circular rna circrna_000203 aggravates cardiac hypertrophy via suppressing mir-26b-5p and mir-140-3p binding to gata4. Cardiovasc Res. 2020;116(7):1323–1334.
  • Mohr AM, Mott JL. Overview of microrna biology. Semin Liver Dis. 2015;35(1):3–11.
  • Zhang L, Liao Y, Tang L. Microrna-34 family: a potential tumor suppressor and therapeutic candidate in cancer. J Exp Clin Cancer Res. 2019;38(1):53.
  • Gu Y, Zhang Y, Zhao C, et al. Serum micrornas as potential biomarkers of mandibular prognathism. Oral Dis. 2014;20(1):55–61.
  • Liu H, Liu Y, Bian Z, et al. Circular rna yap1 inhibits the proliferation and invasion of gastric cancer cells by regulating the mir-367-5p/p27 (kip1) axis. Mol Cancer. 2018;17(1):151.
  • Jin L, Zhang Y, Jiang Y, et al. Circular RNA Rbms1 inhibited the development of myocardial ischemia reperfusion injury by regulating miR-92a/BCL2L11 signaling pathway. Bioengineered. 2022;13(2):3082–3092.
  • Fang L, Xu X, Lu Y, et al. Long noncoding RNA SNHG8 accelerates acute gouty arthritis development by upregulating AP3D1 in mice. Bioengineered. 2021;12(2):9803–9815.
  • Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016;119(1):91–112.
  • Xiao L, Wang W, Zhao J, et al. Lncrna malat1 promotes cell proliferation and invasion by regulating the mir-101/ezh2 axis in oral squamous cell carcinoma. Oncol Lett. 2020;20(5):164.
  • Wang L, Song H, Yang S. MicroRNA-206 has a bright application prospect in the diagnosis of cases with oral cancer. J Cell Mol Med. 2021;25(17):8169–8173.
  • Francula-Zaninovic S, Nola IA. Management of measurable variable cardiovascular disease’ risk factors. Curr Cardiol Rev. 2018;14(3):153–163.
  • Leong DP, Joseph PG, McKee M, et al. Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circ Res. 2017;121(6):695–710.
  • Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–212.
  • Aymong ED, Ramanathan K, Buller CE. Pathophysiology of cardiogenic shock complicating acute myocardial infarction. Med Clin North Am. 2007;91(4):701–712. xii.
  • Yoshimura C, Nagasaka A, Kurose H, et al. Efferocytosis during myocardial infarction. J Biochem. 2020;168(1):1–6.
  • Luo KQ, Long HB, Xu BC. Reduced apoptosis after acute myocardial infarction by simvastatin. Cell Biochem Biophys. 2015;71(2):735–740.
  • Liu X, Wang M, Li Q, et al. Circrna acap2 induces myocardial apoptosis after myocardial infarction by sponging mir-29. Minerva Med. 2020;113(1):128-134.
  • Zhai C, Qian G, Wu H, et al. Knockdown of circ_0060745 alleviates acute myocardial infarction by suppressing nf-kappab activation. J Cell Mol Med. 2020;24(21):12401–12410.
  • Pan G, Mao A, Liu J, et al. Circular rna hsa_circ_0061825 (circ-tff1) contributes to breast cancer progression through targeting mir-326/tff1 signalling. Cell Prolif. 2020;53(2):e12720.
  • Lei B, Huang Y, Zhou Z, et al. Circular rna hsa_circ_0076248 promotes oncogenesis of glioma by sponging mir-181a to modulate sirt1 expression. J Cell Biochem. 2019;120(4):6698–6708.
  • Zhang L, Deng M, Lu A, et al. Sodium butyrate attenuates angiotensin ii-induced cardiac hypertrophy by inhibiting COX2/pge2 pathway via a hdac5/hdac6-dependent mechanism. J Cell Mol Med. 2019; 23(12):8139–8150.